INDIANAPOLIS, Sept. 13 Roche Diagnostics today announcedthe U.S. launch of the cobas c 111 system, a clinical chemistry analyzerdesigned specifically for low- to medium-volume laboratories. The ...

VALIDATE® SP1, specifically targeted for Roche cobas® and Roche COBAS INTEGRA® analyzers, used in conjunction with VALIDATE® SP2 & SP3, offers easy, fast, efficient linearity and calibration ...

Roche (RHHBY) announced that its cobas 6800/8800 systems – two integrated and fully automated molecular testing systems for blood and plasma donor screening are commercially available in markets which ...

Doctors in the US will have a new tool to help tackle the growing epidemic of diabetes after the FDA approved Roche’s assay as the first blood sugar test to diagnose the condition. Roche’s Cobas ...

(RTTNews) - Biopharmaceutical company Roche Holding AG (RHHBY), announced on Tuesday that its cobas HPV test for use on the cobas 6800/8800 Systems has been awarded the World Health Organization (WHO) ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announces an expanded CE mark indication for the cobas® 4800 HPV Test. The newly expanded indication for the cobas® 4800 HPV Test as a primary screen means Pap ...

HERLEV, Denmark, May 8, 2025 /PRNewswire/ -- Nordic Bioscience announces that its PRO-C3 test is launched by Roche Diagnostics on their cobas analysers. The Roche Elecsys® PRO-C3, used with the ADAPT ...

Roche has announced the commercial availability in countries that accept the CE mark1 of the cobas® EGFR Mutation Test v2, the first oncology assay from Roche that utilises either plasma or tumour ...

Roche launches the cobas® pulse system, an industry first professional blood glucose management solution with mobile digital health capabilities to improve patient care Handheld blood glucose ...

(RTTNews) - Roche (RHHBY) announced the launch of the cobas pulse system in select countries accepting the CE Mark. The device marks Roche Diagnostics' newest generation of connected point of care ...